Caption Management, LLC Allogene Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $630,300 - $829,200	-30,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.79 - $39.02 $773,700 - $1.17 Million	30,000 New	30,000 $1.06 Million
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $3.64 Million - $5.06 Million	-112,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $1.56 Million - $4.59 Million	85,000 Added 309.09%	112,500 $4.82 Million
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $45,550 - $70,625	-2,500 Reduced 8.33%	27,500 $535,000
Q4 2019 Feb 13, 2020	SELL	$24.82 - $31.4 $831,470 - $1.05 Million	-33,500 Reduced 52.76%	30,000 $780,000
Q3 2019 Nov 14, 2019	BUY	$26.11 - $32.99 $1.66 Million - $2.09 Million	63,500 New	63,500 $1.73 Million

165

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $278M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.